Calidi Biotherapeutics Inc. (CLDI)

US · Healthcare · Biotechnology

$0.70+3.11%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-4.2M

EPS

$-2.94

Market cap

$2.5M

Forward P/E

0.0

P/B

0.62

Book value

$1.50

EPS (TTM)

$-36.47

52-week high

$24.96

52-week low

$0.62

50-day MA

$1.03

200-day MA

$4.20

Beta

1.37

Analysts rate Calidi Biotherapeutics Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $120.00.

Insiders

0.61%

Institutions

0.93%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Calidi Biotherapeutics Inc. — free to start.

Data updated 2026-11-07.